Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach
Yang Liu(The Ohio State University), Terence M. Williams(City Of Hope National Medical Center)
Cited by 7
Related Papers
Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair
|Nucleic Acids Research|2021|68
Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
|Molecular Therapy — Nucleic Acids|2023|24
JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis
|Molecular Therapy — Oncolytics|2023|6